Mallory O'Connor is an experienced public policy professional with a strong background in healthcare policy and advocacy. Currently serving as Executive Director of Public Policy at Mallinckrodt Pharmaceuticals since May 2019, O'Connor previously held leadership roles at the Biotechnology Innovation Organization and Grifols, where responsibilities included managing public policy initiatives, educating legislators, and overseeing regulatory compliance. O'Connor's earlier experience includes research assistance at The George Washington University School of Medicine and Health Sciences, and working with the U.S. Department of Health and Human Services. O'Connor holds a Bachelor of Science in Biology and Spanish from Arizona State University and a Master of Public Health in Health Policy from The George Washington University.